Ultrastructural changes in muscle cells of patients with collagen VI-related myopathies

Muscles, Ligaments and Tendons Journal

Volumn 3, Issue 4, 2013, Pages 281-286

  Tagliavini, Francesca ^a   Sardone, Francesca ^a   Squarzoni, Stefano ^a   Maraldi, Nadir Mario ^a   Merlini, Luciano ^b   Faldini, Cesare ^c   Sabatelli, Patrizia ^a  

^a CNR   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Collagen VI; Mitochondria; mPTP; Scanning electron microscopy back scattered imaging; Transmission electron microscopy

Indexed keywords

EID: 84894458465     PISSN: None     EISSN: 22404554     Source Type: Journal    
DOI: 10.11138/mltj/2013.3.4.281     Document Type: Article

References (25)

1. Keene DR, Engvall E, Glanville RW. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network. The Journal of cell biology 1988; 107(5): 1995-2006.
2. Kuo HJ, Maslen CL, Keene DR, Glanville RW. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem 1997; 272(42): 26522-26529.
3. Engvall E, Hessle H, Klier G. Molecular assembly, secretion, and matrix deposition of type VI collagen. The Journal of cell biology 1986; 102(3): 703-10.
4. Gara SK, Grumati P, Urciuolo A, et al. Three novel collagen VI chains with high homology to the alpha3 chain. J Biol Chem 2008; 283(16): 10658-10670.
5. Bertini E, Pepe G. Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Eur J Paediatr Neurol 2002; 6(4): 193-198.
6. Merlini L, Morandi L, Granata C, Ballestrazzi A. Bethlem myopathy: early-onset benign autosomal dominant myopathy with contractures. Description of two new families. Neuromuscul Disord 1994; 4(5-6): 503-511.
7. Merlini L, Martoni E, Grumati P, et al. Autosomal recessive myosclerosis myopathy is a collagen VI disorder. Neurology 2008; 71(16): 1245-1253.
8. Bernardi P, Krauskopf A, Basso E, et al. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 2006; 273(10): 2077-2099.
9. Angelin A, Tiepolo T, Sabatelli P, et al. Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci U S A 2007; 104(3): 991-996.
10. Merlini L, Bernardi P. Therapy of collagen VI-related myopathies (Bethlem and Ullrich). Neurotherapeutics 2008; (4): 613-618.
11. Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989; 337(6206): 476-478.
12. Tiepolo T, Angelin A, Palma E, et al. The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/-myopathic mice. Br J Pharmacol 2009; 157(6): 1045-1052.
13. Palma E, Tiepolo T, Angelin A, et al. Genetic ablation of cyclophilin D rescues mitochondrial defects and prevents muscle apoptosis in collagen VI myopathic mice. Human molecular genetics 2009; 18(11): 2024-2031.
14. Grumati P, Coletto L, Sabatelli P, et al. Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat Med 2010; 16(11): 1313-20.
15. Telfer WR, Busta AS, Bonnemann CG, Feldman EL, Dowling JJ. Zebrafish models of collagen VI-related myopathies. Human molecular genetics 2010; 19(12): 2433-2444.
16. Azzolin L, Basso E, Argenton F, Bernardi P. Mitochondrial Ca2+ transport and permeability transition in zebrafish (Danio rerio). Biochim Biophys Acta 2010; 1797(11): 1775-1779.
17. Merlini L, Sabatelli P, Armaroli A, et al. Cyclosporine A in Ullrich congenital muscular dystrophy: long-term results. Oxid Med Cell Longev (2011); ID139194.
18. Chazotte B. Labeling mitochondria with MitoTracker dyes. Cold Spring Harb Protoc 2011; 2011(8): 990-992.
19. Thiery G. Colorations permettant l'étude des coupes épaisses, leur intéret en miscoscopie électronique. J Miscosc 1973; 17: 101A.
20. Irwin WA, Bergamin N, Sabatelli P, et al. Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nature genetics 2003; 35(4): 367-371.
21. Sabatelli P, Palma E, Angelin A, et al. Critical evaluation of the use of cell cultures for inclusion in clinical trials of patients affected by collagen VI myopathies. Journal of cellular physiology 2012; 227(7): 2927-2935.
22. Bernardi P, Bonaldo P. Mitochondrial dysfunction and defective autophagy in the pathogenesis of collagen VI muscular dystrophies. Cold Spring Harbor perspectives in biology 2013; 5(5): a011387.
23. Pellegrini C, Zulian A, Gualandi F, et al. Melanocytes-a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy. Journal of cellular physiology 2013; 228(6): 1323-1331.
24. Frank S, Gaume B, Bergmann-Leitner ES, et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Developmental cell 2001; 1(4): 515-525.
25. McNiven MA, Cao H, Pitts KR, Yoon Y. The dynamin family of mechanoenzymes: pinching in new places. Trends in biochemical sciences 2000; 25(3): 115-120.